-
A 3-year randomized, double-blind clinical trial in 206 sites throughout the world compared bazedoxifene (20 mg or 40 mg) and raloxifene (60 mg) with placebo.
-
A randomized, double-blind, placebo-controlled trial comparing Ginkgo biloba with placebo for the prevention of dementia enrolled 3069 elderly individuals (older than age 75) in 5 academic centers in the United States.
-
In this issue: Drug combinations for hypertension; tenecteplase for out-of-hospital cardiac arrest; CAM most commonly used for back, neck, and arthritis pain; FDA Actions.
-
-
For more than a decade, organizations like the american Heart Association (AHA) and the Centers for Disease Control and Prevention (CDC) have been drawing attention to the prevalence and effects of cardiovascular disease (CVD) among women.
-
The purpose of this study was to determine if antioxidant supplementation during pregnancy reduces the incidence of premature rupture of the membranes (PROM).
-
Approximately 38% of adults in the united states aged 18 years and older and nearly 12% of U.S. children aged 17 years and younger use some form of complementary and alternative medicine (CAM), according to a nationwide government survey conducted in 2007.
-
With the inauguration of President Barack Obama and with expanded Democratic majorities in both chambers of Congress, reproductive health supporters in the administration, in Congress, and outside the government are entering the new year with renewed optimism.
-
When it comes to current methods of delivery of hormonal contraception, women now can choose among pill, patch, ring, implant, and intrauterine forms of birth control.
-
Results from a just-published study indicate that teens who are treated for pelvic inflammatory disease (PID) are at risk for subsequent sexually transmitted infections (STIs) and/or PID for 48 months.1 What can clinicians do to stem subsequent infection?
